Active Impact Investments

Active Impact Investments seeks to invest in early-stage companies operating in clean energy, transportation, infrastructure, sustainable food & water, and the circular & sharing economy sector.

Clean Energy CleanTech Impact Investing Service Industry

$120M

Latest Funding

Seed

Latest Funding Stage

2023-11-29

Funding Date

11

Employees

Canada

Location

North Vancouver, British Columbia

City & State

Key Contacts
Unlock Contact Information

Upgrade to access founder details

Upgrade Now
Open Positions
View Careers Page
Hiring For
{ "Hiring_For_Raw": {"category": "Engineering/Software Development" "roles": "Wildfire Weather Forecaster"} {"category": "Human Resources" "roles": "Head of People & Culture"} {"category": "Sales" "roles": "Head of Sales" "Sales and Growth Specialists"} {"category": "Finance/Accounting" "roles": "CFO"} {"category": "Executive/C-Suite" "roles": "CEO" "COO" "CRO"} {"category": "General/Other" "roles": "Climate Tech Startup roles"} "additional_notes": { "seniority_levels": "specialist" "C-suite" "industry_focus": "climate-related roles and startups" "work_arrangements": "remote" "hybrid" "general_applications": true } }
Unlock Tech Stack Data

Upgrade to access technology insights

Upgrade Now

Similar Startups

STAX Engineering
STAX Engineering Logo

The STAX mission is to help 1 billion people significantly through new technologies that promote health, sustainability, reduced environmental toxins, and reduced global warming.

Floodbase
Floodbase  Logo

Floodbase provides feature that enables insurers to add flood protection to existing wind parametric policies, creating the first-ever comprehensive hurricane parametric insurance offerings.This technology will allow flood insurance to be extended to every corner of the globe, closing a protection gap that cannot be closed without parametricinsurance.

uFraction8
uFraction8  Logo

uFraction8 provides scalable bioprocessing technology enabling biomass filtration, separation and dewatering, used with wide range of microbes like micro algae, yeast and bacteria, sorting biomass from culture medium with no harm and no flocculants unlike centrifuges, filters and membranes.

Stablepharma
Stablepharma Logo

Stablepharma’s technology platform, StablevaX™ converts existing approved vaccines, therapeutics and diagnostics into fridge free thermostable products that do not require refrigeration to preserve them, thereby addressing the global challenges of the cold chain. Stablepharma’s R&D team have identified up to 60 vaccine candidates that could be suitable for StablevaX™ technology.